Fructose Metabolism Derangement describes the pathological alteration in how the body processes dietary fructose, often leading to detrimental metabolic consequences when intake exceeds hepatic processing capacity. Unlike glucose, fructose metabolism bypasses key regulatory checkpoints like phosphofructokinase, leading to rapid substrate flux toward lipogenesis in the liver. This derangement is a significant contributor to non-alcoholic fatty liver disease and subsequent insulin resistance. Clinical assessment focuses on identifying this metabolic inefficiency.
Origin
The term derives from biochemistry, specifically the study of carbohydrate pathways, gaining clinical relevance as high-fructose corn syrup consumption increased globally. Its origin is tied to recognizing the unique, less regulated metabolic fate of fructose compared to glucose. This distinction is crucial in understanding modern metabolic syndrome etiology.
Mechanism
In the liver, fructose is rapidly phosphorylated by fructokinase, flooding the pathway downstream of the primary glucose control point. This leads to accelerated de novo lipogenesis (DNL), producing triglycerides that accumulate as hepatic fat. Furthermore, this process can generate uric acid and deplete cellular ATP, inducing cellular stress. This metabolic cascade ultimately promotes hepatic insulin resistance, disrupting systemic glucose homeostasis.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.